{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:14:23Z","timestamp":1790435663577,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,4,7]],"date-time":"2013-04-07T00:00:00Z","timestamp":1365292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12032-013-0568-x","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T11:11:16Z","timestamp":1365246676000},"source":"Crossref","is-referenced-by-count":21,"title":["Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report"],"prefix":"10.1007","volume":"30","author":[{"given":"Wade","family":"Iams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathyrn Eby","family":"Beckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne T.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana Gupta","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,7]]},"reference":[{"issue":"7","key":"568_CR1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00002018-200124070-00002","volume":"24","author":"R Pisoni","year":"2001","unstructured":"Pisoni R, Ruggenenti P, Remuzzi G. Drug-induced thrombotic microangiopathy; incidence, prevention, and management. Drug Saf. 2001;24(7):491\u2013501.","journal-title":"Drug Saf"},{"key":"568_CR2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","volume":"2","author":"W Symmers","year":"1952","unstructured":"Symmers W. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy). Br Med J. 1952;2:897\u2013903.","journal-title":"Br Med J"},{"key":"568_CR3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12032-009-9333-6","volume":"27","author":"K Siau","year":"2010","unstructured":"Siau K, Varughese M. Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: a case report. Med Oncol. 2010;27:1057\u20139.","journal-title":"Med Oncol"},{"key":"568_CR4","first-page":"271","volume-title":"Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura, (kidney disease S v. 10)","author":"AJ Murgo","year":"1992","unstructured":"Murgo AJ. Cancer- and chemotherapy-associated thrombotic microangiopathy. In: Kaplan BS, Trompeter RS, Moake JL, editors. Hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura, (kidney disease S v. 10), vol. 22. New York: Marcel Dekker Ltd; 1992. p. 271\u201395."},{"key":"568_CR5","doi-asserted-by":"crossref","unstructured":"Rahdi M, Carpenter SL. Thrombotic microangiopathies. ISRN Hematol. 2012.","DOI":"10.5402\/2012\/310596"},{"issue":"8","key":"568_CR6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. NEJM. 2002;347(8):589\u2013600.","journal-title":"NEJM"},{"key":"568_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","volume":"91","author":"K Lechner","year":"2012","unstructured":"Lechner K, Obermeier HL. Cancer-related microangiopathic hemolytic anemia. Medicine. 2012;91:195\u2013205.","journal-title":"Medicine"},{"issue":"5","key":"568_CR8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/1097-0142(19890901)64:5<1017::AID-CNCR2820640508>3.0.CO;2-N","volume":"64","author":"RW Walker","year":"1989","unstructured":"Walker RW, Rosenblum MK, Kempin SJ, Christian MC. Carboplatin-associated thrombotic microangiopathic hemolytic anemia. Cancer. 1989;64(5):1017\u201320.","journal-title":"Cancer"},{"issue":"1","key":"568_CR9","first-page":"193","volume":"18","author":"DC Fisher","year":"1996","unstructured":"Fisher DC, Sherrill GB, Hussein A, Rubin P, Vredenburgh JJ, Elkordy M, Ross M, Petros W, Peters WP. Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer. Bone Marrow Transpl. 1996;18(1):193\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"568_CR10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1526-0968.2003.00127.x","volume":"8","author":"JS Dlott","year":"2004","unstructured":"Dlott JS, Danielson CFM, Blue-Hnidy DE, McCarthy LJ. Drug induced thrombotic thrombocytopenic purpura\/haemolytic uremic syndrome: a concise review. Ther Apher Dial. 2004;8(2):102\u201311.","journal-title":"Ther Apher Dial"},{"issue":"7-8","key":"568_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1060028089023007-810","volume":"23","author":"SM Fields","year":"1989","unstructured":"Fields SM, Lindley CM. Thrombotic microangiopathy associated with chemotherapy: case report and review of the literature. DICP. 1989;23(7-8):582\u20138.","journal-title":"DICP"},{"issue":"5","key":"568_CR12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.1985.3.5.723","volume":"3","author":"JE Cantrell Jr","year":"1985","unstructured":"Cantrell JE Jr, Phillips TM, Schein PS. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol. 1985;3(5):723\u201334.","journal-title":"J Clin Oncol"},{"issue":"5","key":"568_CR13","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/1097-0142(19930301)71:5<1882::AID-CNCR2820710527>3.0.CO;2-E","volume":"71","author":"HW Snyder Jr","year":"1993","unstructured":"Snyder HW Jr, Mittelman A, Oral A, Messerschmidt GL, et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer. 1993;71(5):1882\u201392.","journal-title":"Cancer"},{"issue":"2","key":"568_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jvir.2008.10.025","volume":"20","author":"AA Onitilo","year":"2009","unstructured":"Onitilo AA, Engel JM, Clouse LH, Gerndt KM. Successful treatment of mitomycin-induced thrombotic thrombocytopenic purpura with rituximab. Vasc Interv Radiol. 2009;20(2):275\u20136.","journal-title":"Vasc Interv Radiol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0568-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0568-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:58:16Z","timestamp":1595638696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,7]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0568-x","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,7]]},"article-number":"568"}}